Clinical and Molecular Hepatology (Jul 2025)

CD36 promotes iron accumulation and dysfunction in CD8 T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma

  • Yifei Qin,
  • Fei Huo,
  • Zhuan Feng,
  • Jialu Hou,
  • Yaxin Ding,
  • Quancheng Wang,
  • Yu Gui,
  • Ziwei Yang,
  • Jiali Yang,
  • Gang Zhou,
  • Ling Li,
  • Jianli Jiang,
  • Lingmin Kong,
  • Shijie Wang,
  • Gang Nan,
  • Dingqiao Xu,
  • Xiaohang Xie,
  • Lijuan Wang,
  • Qian He,
  • Ruibin Yang,
  • Peng Lin,
  • Huijie Bian,
  • Zhi-Nan Chen,
  • Jiao Wu

DOI
https://doi.org/10.3350/cmh.2024.0948
Journal volume & issue
Vol. 31, no. 3
pp. 960 – 980

Abstract

Read online

Background/Aims The identification of factors that lead to CD8+ T cell dysfunction within the tumor microenvironment (TME) holds great promise for the development of innovative immunotherapies. However, the mechanisms underlying the exhausted phenotype of CD8+ T cells infiltrating early-stage hepatocellular carcinoma (HCC) tumors remain unclear. Methods Single-cell RNA sequencing was performed using a murine HCC model. Flow cytometry and additional experimental approaches were employed to investigate the mechanisms of CD8+ T cell exhaustion. Results CD8+ T cells infiltrating early-stage HCC exhibited a functionally exhausted phenotype, which escalated with HCC progression. At early stages of HCC, the TME was characterized by significant iron accumulation. Moreover, tumor-infiltrating CD8+ T cells in murine HCC exhibited higher levels of intracellular ferrous iron compared to splenic CD8+ T. This excessive iron led to increased lipid peroxide levels and impaired the effector function of CD8+ T cells. Mechanistically, CD36 upregulated the iron uptake protein transferrin receptor 1 (TfR1) by mediating the activation of oxidized low-density lipoprotein (oxLDL)-p38-CEBPB axis. Depletion of CD36 in CD8+ T cells inhibited the upregulation of TfR1 and the increase of iron levels. Furthermore, constitutively activated nuclear factor erythroid 2-related factor 2 (NRF2) effectively suppressed lipid peroxidation, thereby preserving the effector functions of intratumoral CD8+ T cells and ultimately inhibiting tumor growth. Conclusions Our findings reveal a previously unidentified mechanism mediated by CD36 that regulates the progressive dysfunction of CD8+ T cells in early HCC TME and provide a potential novel therapeutic approach to restore T cell function.

Keywords